The global Retroviral Vectors market  size is set to grow from  US$ 472 million in 2024 to US$ 794 million in 2030; it is expected to grow at a CAGR of 9.1% from 2024 to 2030.

Global Retroviral Vectors Market Growth and Outlook 2025-31

The global Retroviral Vectors market size is predicted to grow from US$ 472 million in 2024 to US$ 794 million in 2030; it is expected to grow at a CAGR of 9.1% from 2024 to 2030. Retroviral vectors transduce a wide range of hard-to-infect dividing cells and integrate into the host genome, which makes them ideal for long-term, stable expression of your transgene.As the number and variety of planned CAR-T and gene therapy trials increases with each year, the need for commercial-grade retrovirus also continues to grow. United States market for Retroviral Vectors is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030. China market for Retroviral Vectors is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030. Europe market for Retroviral Vectors is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030. Global key Retroviral Vectors players cover Merck KGaA, Biovian, Esco Lifesciences Group, ABL, Inc., Genezen, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023. LPI (LP Information) newest research report, the Retroviral Vectors Industry Forecast looks at past sales and reviews total world Retroviral Vectors sales in 2023, providing a comprehensive analysis by region and market sector of projected Retroviral Vectors sales for 2024 through 2030. With Retroviral Vectors sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Retroviral Vectors industry. This Insight Report provides a comprehensive analysis of the global Retroviral Vectors landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Retroviral Vectors portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Retroviral Vectors market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Retroviral Vectors and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Retroviral Vectors. This report presents a comprehensive overview, market shares, and growth opportunities of Retroviral Vectors market by product type, application, key players and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Research / Preclinical Grade &nbsp;&nbsp;&nbsp; Clinical Grade &nbsp;&nbsp;&nbsp; Commercial Grade Segmentation by Application: &nbsp;&nbsp;&nbsp; Gene Therapy &nbsp;&nbsp;&nbsp; Vaccine Development &nbsp;&nbsp;&nbsp; Cell Therapy This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Merck KGaA &nbsp;&nbsp;&nbsp; Biovian &nbsp;&nbsp;&nbsp; Esco Lifesciences Group &nbsp;&nbsp;&nbsp; ABL, Inc. &nbsp;&nbsp;&nbsp; Genezen &nbsp;&nbsp;&nbsp; AGC Inc. Group (AGC Biologics) &nbsp;&nbsp;&nbsp; Thermo Fisher Scientific Inc. &nbsp;&nbsp;&nbsp; Creative Biogene &nbsp;&nbsp;&nbsp; CD Bioparticles &nbsp;&nbsp;&nbsp; Charles River Laboratories &nbsp;&nbsp;&nbsp; Avid Bioservices, Inc.

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Retroviral Vectors Market Size 2019-2030 &nbsp;2.1.2 Retroviral Vectors Market Size CAGR by Region (2019 VS 2023 VS 2030) &nbsp;2.1.3 World Current & Future Analysis for Retroviral Vectors by Country/Region, 2019, 2023 & 2030 &nbsp;2.2 Retroviral Vectors Segment by Type &nbsp;2.2.1 Research / Preclinical Grade &nbsp;2.2.2 Clinical Grade &nbsp;2.2.3 Commercial Grade &nbsp;2.3 Retroviral Vectors Market Size by Type &nbsp;2.3.1 Retroviral Vectors Market Size CAGR by Type (2019 VS 2023 VS 2030) &nbsp;2.3.2 Global Retroviral Vectors Market Size Market Share by Type (2019-2024) &nbsp;2.4 Retroviral Vectors Segment by Application &nbsp;2.4.1 Gene Therapy &nbsp;2.4.2 Vaccine Development &nbsp;2.4.3 Cell Therapy &nbsp;2.5 Retroviral Vectors Market Size by Application &nbsp;2.5.1 Retroviral Vectors Market Size CAGR by Application (2019 VS 2023 VS 2030) &nbsp;2.5.2 Global Retroviral Vectors Market Size Market Share by Application (2019-2024) 3 Retroviral Vectors Market Size by Player &nbsp;3.1 Retroviral Vectors Market Size Market Share by Player &nbsp;3.1.1 Global Retroviral Vectors Revenue by Player (2019-2024) &nbsp;3.1.2 Global Retroviral Vectors Revenue Market Share by Player (2019-2024) &nbsp;3.2 Global Retroviral Vectors Key Players Head office and Products Offered &nbsp;3.3 Market Concentration Rate Analysis &nbsp;3.3.1 Competition Landscape Analysis &nbsp;3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024) &nbsp;3.4 New Products and Potential Entrants &nbsp;3.5 Mergers & Acquisitions, Expansion 4 Retroviral Vectors by Region &nbsp;4.1 Retroviral Vectors Market Size by Region (2019-2024) &nbsp;4.2 Global Retroviral Vectors Annual Revenue by Country/Region (2019-2024) &nbsp;4.3 Americas Retroviral Vectors Market Size Growth (2019-2024) &nbsp;4.4 APAC Retroviral Vectors Market Size Growth (2019-2024) &nbsp;4.5 Europe Retroviral Vectors Market Size Growth (2019-2024) &nbsp;4.6 Middle East & Africa Retroviral Vectors Market Size Growth (2019-2024) 5 Americas &nbsp;5.1 Americas Retroviral Vectors Market Size by Country (2019-2024) &nbsp;5.2 Americas Retroviral Vectors Market Size by Type (2019-2024) &nbsp;5.3 Americas Retroviral Vectors Market Size by Application (2019-2024) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Retroviral Vectors Market Size by Region (2019-2024) &nbsp;6.2 APAC Retroviral Vectors Market Size by Type (2019-2024) &nbsp;6.3 APAC Retroviral Vectors Market Size by Application (2019-2024) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia 7 Europe &nbsp;7.1 Europe Retroviral Vectors Market Size by Country (2019-2024) &nbsp;7.2 Europe Retroviral Vectors Market Size by Type (2019-2024) &nbsp;7.3 Europe Retroviral Vectors Market Size by Application (2019-2024) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Retroviral Vectors by Region (2019-2024) &nbsp;8.2 Middle East & Africa Retroviral Vectors Market Size by Type (2019-2024) &nbsp;8.3 Middle East & Africa Retroviral Vectors Market Size by Application (2019-2024) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Global Retroviral Vectors Market Forecast &nbsp;10.1 Global Retroviral Vectors Forecast by Region (2025-2030) &nbsp;10.1.1 Global Retroviral Vectors Forecast by Region (2025-2030) &nbsp;10.1.2 Americas Retroviral Vectors Forecast &nbsp;10.1.3 APAC Retroviral Vectors Forecast &nbsp;10.1.4 Europe Retroviral Vectors Forecast &nbsp;10.1.5 Middle East & Africa Retroviral Vectors Forecast &nbsp;10.2 Americas Retroviral Vectors Forecast by Country (2025-2030) &nbsp;10.2.1 United States Market Retroviral Vectors Forecast &nbsp;10.2.2 Canada Market Retroviral Vectors Forecast &nbsp;10.2.3 Mexico Market Retroviral Vectors Forecast &nbsp;10.2.4 Brazil Market Retroviral Vectors Forecast &nbsp;10.3 APAC Retroviral Vectors Forecast by Region (2025-2030) &nbsp;10.3.1 China Retroviral Vectors Market Forecast &nbsp;10.3.2 Japan Market Retroviral Vectors Forecast &nbsp;10.3.3 Korea Market Retroviral Vectors Forecast &nbsp;10.3.4 Southeast Asia Market Retroviral Vectors Forecast &nbsp;10.3.5 India Market Retroviral Vectors Forecast &nbsp;10.3.6 Australia Market Retroviral Vectors Forecast &nbsp;10.4 Europe Retroviral Vectors Forecast by Country (2025-2030) &nbsp;10.4.1 Germany Market Retroviral Vectors Forecast &nbsp;10.4.2 France Market Retroviral Vectors Forecast &nbsp;10.4.3 UK Market Retroviral Vectors Forecast &nbsp;10.4.4 Italy Market Retroviral Vectors Forecast &nbsp;10.4.5 Russia Market Retroviral Vectors Forecast &nbsp;10.5 Middle East & Africa Retroviral Vectors Forecast by Region (2025-2030) &nbsp;10.5.1 Egypt Market Retroviral Vectors Forecast &nbsp;10.5.2 South Africa Market Retroviral Vectors Forecast &nbsp;10.5.3 Israel Market Retroviral Vectors Forecast &nbsp;10.5.4 Turkey Market Retroviral Vectors Forecast &nbsp;10.6 Global Retroviral Vectors Forecast by Type (2025-2030) &nbsp;10.7 Global Retroviral Vectors Forecast by Application (2025-2030) &nbsp;10.7.1 GCC Countries Market Retroviral Vectors Forecast 11 Key Players Analysis &nbsp;11.1 Merck KGaA &nbsp;11.1.1 Merck KGaA Company Information &nbsp;11.1.2 Merck KGaA Retroviral Vectors Product Offered &nbsp;11.1.3 Merck KGaA Retroviral Vectors Revenue, Gross Margin and Market Share (2019-2024) &nbsp;11.1.4 Merck KGaA Main Business Overview &nbsp;11.1.5 Merck KGaA Latest Developments &nbsp;11.2 Biovian &nbsp;11.2.1 Biovian Company Information &nbsp;11.2.2 Biovian Retroviral Vectors Product Offered &nbsp;11.2.3 Biovian Retroviral Vectors Revenue, Gross Margin and Market Share (2019-2024) &nbsp;11.2.4 Biovian Main Business Overview &nbsp;11.2.5 Biovian Latest Developments &nbsp;11.3 Esco Lifesciences Group &nbsp;11.3.1 Esco Lifesciences Group Company Information &nbsp;11.3.2 Esco Lifesciences Group Retroviral Vectors Product Offered &nbsp;11.3.3 Esco Lifesciences Group Retroviral Vectors Revenue, Gross Margin and Market Share (2019-2024) &nbsp;11.3.4 Esco Lifesciences Group Main Business Overview &nbsp;11.3.5 Esco Lifesciences Group Latest Developments &nbsp;11.4 ABL, Inc. &nbsp;11.4.1 ABL, Inc. Company Information &nbsp;11.4.2 ABL, Inc. Retroviral Vectors Product Offered &nbsp;11.4.3 ABL, Inc. Retroviral Vectors Revenue, Gross Margin and Market Share (2019-2024) &nbsp;11.4.4 ABL, Inc. Main Business Overview &nbsp;11.4.5 ABL, Inc. Latest Developments &nbsp;11.5 Genezen &nbsp;11.5.1 Genezen Company Information &nbsp;11.5.2 Genezen Retroviral Vectors Product Offered &nbsp;11.5.3 Genezen Retroviral Vectors Revenue, Gross Margin and Market Share (2019-2024) &nbsp;11.5.4 Genezen Main Business Overview &nbsp;11.5.5 Genezen Latest Developments &nbsp;11.6 AGC Inc. Group (AGC Biologics) &nbsp;11.6.1 AGC Inc. Group (AGC Biologics) Company Information &nbsp;11.6.2 AGC Inc. Group (AGC Biologics) Retroviral Vectors Product Offered &nbsp;11.6.3 AGC Inc. Group (AGC Biologics) Retroviral Vectors Revenue, Gross Margin and Market Share (2019-2024) &nbsp;11.6.4 AGC Inc. Group (AGC Biologics) Main Business Overview &nbsp;11.6.5 AGC Inc. Group (AGC Biologics) Latest Developments &nbsp;11.7 Thermo Fisher Scientific Inc. &nbsp;11.7.1 Thermo Fisher Scientific Inc. Company Information &nbsp;11.7.2 Thermo Fisher Scientific Inc. Retroviral Vectors Product Offered &nbsp;11.7.3 Thermo Fisher Scientific Inc. Retroviral Vectors Revenue, Gross Margin and Market Share (2019-2024) &nbsp;11.7.4 Thermo Fisher Scientific Inc. Main Business Overview &nbsp;11.7.5 Thermo Fisher Scientific Inc. Latest Developments &nbsp;11.8 Creative Biogene &nbsp;11.8.1 Creative Biogene Company Information &nbsp;11.8.2 Creative Biogene Retroviral Vectors Product Offered &nbsp;11.8.3 Creative Biogene Retroviral Vectors Revenue, Gross Margin and Market Share (2019-2024) &nbsp;11.8.4 Creative Biogene Main Business Overview &nbsp;11.8.5 Creative Biogene Latest Developments &nbsp;11.9 CD Bioparticles &nbsp;11.9.1 CD Bioparticles Company Information &nbsp;11.9.2 CD Bioparticles Retroviral Vectors Product Offered &nbsp;11.9.3 CD Bioparticles Retroviral Vectors Revenue, Gross Margin and Market Share (2019-2024) &nbsp;11.9.4 CD Bioparticles Main Business Overview &nbsp;11.9.5 CD Bioparticles Latest Developments &nbsp;11.10 Charles River Laboratories &nbsp;11.10.1 Charles River Laboratories Company Information &nbsp;11.10.2 Charles River Laboratories Retroviral Vectors Product Offered &nbsp;11.10.3 Charles River Laboratories Retroviral Vectors Revenue, Gross Margin and Market Share (2019-2024) &nbsp;11.10.4 Charles River Laboratories Main Business Overview &nbsp;11.10.5 Charles River Laboratories Latest Developments &nbsp;11.11 Avid Bioservices, Inc. &nbsp;11.11.1 Avid Bioservices, Inc. Company Information &nbsp;11.11.2 Avid Bioservices, Inc. Retroviral Vectors Product Offered &nbsp;11.11.3 Avid Bioservices, Inc. Retroviral Vectors Revenue, Gross Margin and Market Share (2019-2024) &nbsp;11.11.4 Avid Bioservices, Inc. Main Business Overview &nbsp;11.11.5 Avid Bioservices, Inc. Latest Developments 12 Research Findings and Conclusion

Report	Global Retroviral Vectors Market Growth (Status and Outlook) 2024-2030
Selected License	Multi ID: LPI15757

Buyer Information

Order Summary